{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T09:55:54Z","timestamp":1648720554539},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,11,24]],"date-time":"2007-11-24T00:00:00Z","timestamp":1195862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1007\/s00120-007-1592-2","type":"journal-article","created":{"date-parts":[[2007,11,22]],"date-time":"2007-11-22T14:18:08Z","timestamp":1195741088000},"page":"46-53","source":"Crossref","is-referenced-by-count":9,"title":["Botulinumtoxin in der Therapie der \u00fcberaktiven Blase \u2013 ein \u00dcberblick"],"prefix":"10.1007","volume":"47","author":[{"given":"C.","family":"Seif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Boy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Wefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Dmochowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.M.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.-P.","family":"J\u00fcnemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,11,24]]},"reference":[{"key":"1592_CR1","unstructured":"Alloussi SH, Eichel R, Alloussi S, Lang C (2006) Up to date treatment results of drug refractorical non neurogenic overactive bladder with transurethral intramural intravesical injection of botulinum toxin A. 36th Annual Meeting of the International Continence Society, Christchurch, New Zealand"},{"key":"1592_CR2","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0022-5347(05)00400-3","volume":"175","author":"Altaweel","year":"2006","unstructured":"Altaweel W, Jednack R, Bilodeau C, Corcos J (2006) Repeated intradetrusor botulinum toxin type A in children with neurogenic bladder due to myelomeningocele. J Urol 175: 1102\u20131105","journal-title":"J Urol"},{"key":"1592_CR3","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","volume":"49","author":"Apostolidis","year":"2006","unstructured":"Apostolidis A, Dasgupta P, Fowler CJ (2006) Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 49: 644\u2013650","journal-title":"Eur Urol"},{"key":"1592_CR4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/00365590410015867","volume":"38","author":"Bagi","year":"2004","unstructured":"Bagi P, Biering-Sorensen F (2004) Botulinum toxin A for treatment of neurogenic detrusor overactivity and incontinence in patients with spinal cord lesions. Scand J Urol Nephrol 38: 495\u2013498","journal-title":"Scand J Urol Nephrol"},{"key":"1592_CR5","doi-asserted-by":"crossref","unstructured":"Boy S, Schmid M, Reitz A et al. (2006) Botulinumtoxin injections into the bladder wall \u2013 a morphological evaluation of the injection technique using magnetic resonance imaging. 21st Annual EAU Congress, Paris, France","DOI":"10.1016\/S1569-9056(06)61109-3"},{"key":"1592_CR6","unstructured":"Del Popolo G, Li Marzi V, Panariello G, Lombardi G (2003) English botulinum toxin-A in the treatment of neurogenic detrusor overactivity. 33rd Annual Meeting of the International Continence Society, Florence, Italy"},{"key":"1592_CR7","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-5347(17)42717-0","volume":"139","author":"Dykstra","year":"1988","unstructured":"Dykstra DD, Sidi AA, Scott AB et al. (1988) Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 139: 919\u2013922","journal-title":"J Urol"},{"key":"1592_CR8","first-page":"24","volume":"71","author":"Dykstra","year":"1990","unstructured":"Dykstra DD, Sidi AA (1990) Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study. Arch Phys Med Rehabil 71: 24\u201326","journal-title":"Arch Phys Med Rehabil"},{"key":"1592_CR9","doi-asserted-by":"crossref","unstructured":"Ehren I, Volz D, Farrelly\u00a0E et al. (2006) Treatment with botulinumtoxin A in neurogenic bladder dysfunction \u2013 a randomised double-blind study with Dysport. 21st Annual EAU Congress, Paris, France","DOI":"10.1016\/S1569-9056(06)61111-1"},{"key":"1592_CR10","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/01.ju.0000177477.83991.88","volume":"174","author":"Ghei","year":"2005","unstructured":"Ghei M, Maraj BH, Miller R et al. (2005) Effects of botulinumtoxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial. J Urol 174: 1873\u20131877","journal-title":"J Urol"},{"key":"1592_CR11","first-page":"79","volume":"56","author":"Giannantoni","year":"2004","unstructured":"Giannantoni A, Mearini E, Di Stasi SM et al. (2004) New therapeutic options for refractory neurogenic detrusor overactivity. Minerva Urol Nefrol 56: 79\u201387","journal-title":"Minerva Urol Nefrol"},{"key":"1592_CR12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.ju.0000132152.53532.5d","volume":"172","author":"Giannantoni","year":"2004","unstructured":"Giannantoni A, Di Stasi SM, Stephen RL et al. (2004) Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study. J Urol 172: 240\u2013243","journal-title":"J Urol"},{"key":"1592_CR13","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/S0022-5347(06)00258-8","volume":"175","author":"Giannantoni","year":"2006","unstructured":"Giannantoni A, Di Stasi SM, Nardicchi V et al. (2006) Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity. J Urol 175: 2341\u20132344","journal-title":"J Urol"},{"key":"1592_CR14","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","volume":"47","author":"Grosse","year":"2005","unstructured":"Grosse J, Kramer G, Stohrer M (2005) Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 47: 653\u2013659","journal-title":"Eur Urol"},{"key":"1592_CR15","first-page":"2543","volume":"12","author":"Hajebrahimi","year":"2005","unstructured":"Hajebrahimi S, Altaweel W, Cadoret J et al. (2005) Efficacy of botulinum-A toxin in adults with neurogenic overactive bladder: initial results. Can J Urol 12: 2543\u20132546","journal-title":"Can J Urol"},{"key":"1592_CR16","unstructured":"Karsenty G, Boy S, Reitz A et al. (2005) Botulinum toxin-A in the treatment of neurogenic detrusor overactivity incontinence \u2013 a prospective randomized study to compare 30 vs. 10 injection sites. 35th Annual Meeting of the International Continence Society, Montreal, Quebec, Canada"},{"key":"1592_CR17","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.urology.2006.08.1069","volume":"68","author":"Karsenty","year":"2006","unstructured":"Karsenty G, Reitz A, Lindemann G et al. (2006) Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity. Urology 68: 1193\u20131197","journal-title":"Urology"},{"key":"1592_CR18","unstructured":"Keppenne V, Gaspard Y, Mathantu B et al. (2005) Detrusor injection of botulinum-A toxin for idiopathic overactive bladder syndrome: clinical and urodynamic evaluation. 35th Annual Meeting of the International Continence Society, Montreal, Quebec, Canada"},{"key":"1592_CR19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/nau.20105","volume":"24","author":"Kessler","year":"2005","unstructured":"Kessler TM, Danuser H, Schumacher M et al. (2005) Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity? Neurourol Urodyn 24: 231\u2013236","journal-title":"Neurourol Urodyn"},{"key":"1592_CR20","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.urology.2003.12.007","volume":"63","author":"Kuo","year":"2004","unstructured":"Kuo HC (2004) Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents. Urology 63: 868\u2013872","journal-title":"Urology"},{"key":"1592_CR21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.urology.2005.02.002","volume":"66","author":"Kuo","year":"2005","unstructured":"Kuo HC (2005) Clinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics. Urology 66: 94\u201398","journal-title":"Urology"},{"key":"1592_CR22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.urology.2005.08.016","volume":"67","author":"Kuo","year":"2006","unstructured":"Kuo HC (2006) Therapeutic effects of suburothelial injection of botulinum a toxin for neurogenic detrusor overactivity due to chronic cerebrovascular accident and spinal cord lesions. Urology 67: 232\u2013236","journal-title":"Urology"},{"key":"1592_CR23","first-page":"3291","volume":"13","author":"Lucioni","year":"2006","unstructured":"Lucioni A, Rapp DE, Gong EM et al. (2006) Intravesical botulinum type A toxin injection in patients with overactive bladder: Trigone versus trigone-sparing injection. Can J Urol 13: 3291\u20133295","journal-title":"Can J Urol"},{"key":"1592_CR24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-2003-812520","volume":"35","author":"Lusuardi","year":"2004","unstructured":"Lusuardi L, Nader A, Koen M et al. (2004) Minimally invasive, safe treatment of the neurogenic bladder with botulinum-A-toxin in children with myelomeningocele. Akt Urol 35: 49\u201353","journal-title":"Akt Urol"},{"key":"1592_CR25","first-page":"35","volume":"57","author":"Marte","year":"2005","unstructured":"Marte A, Vessella A, Cautiero P et al. (2005) Efficacy of toxin-A Botulinum for treating intractable bladder hyperactivity in children affected by neuropathic bladder secondary to myelomeningocele: an alternative to enterocystoplasty. Minerva Pediatr 57: 35\u201340","journal-title":"Minerva Pediatr"},{"key":"1592_CR26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1464-410X.2006.06192.x","volume":"98","author":"Patki","year":"2006","unstructured":"Patki PS, Arumugam K, Shah PJ, Craggs M (2006) Botulinum toxin-type A in the treatment of drug-resistant neurogenic detrusor overactivity secondary to traumatic spinal cord injury. BJU Int 98: 77\u201382","journal-title":"BJU Int"},{"key":"1592_CR27","unstructured":"Peeren F, Everaert K, Hoebeke P, Decaestecker K (2005) Successive injections of botulinum A toxine (BOTOX) in paediatric population. 34th Annual Meeting of the International Continence Society, Paris, France"},{"key":"1592_CR28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1098\/rstb.1999.0377","volume":"354","author":"Pellizzari","year":"1999","unstructured":"Pellizzari R, Rossetto O, Schiavo G, Montecucco C (1999) Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses. Philos Trans R Soc Lond B Biol Sci 354: 259\u2013268","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"1592_CR29","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.ju.0000108844.10235.f1","volume":"171","author":"Pistolesi","year":"2004","unstructured":"Pistolesi D, Selli C, Rossi B, Stampacchia G (2004) Botulinum toxin type B for type A resistant bladder spasticity. J Urol 171: 802\u2013803","journal-title":"J Urol"},{"key":"1592_CR30","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.ju.0000169480.43557.31","volume":"174","author":"Popat","year":"2005","unstructured":"Popat R, Apostolidis A, Kalsi V et al. (2005) A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin. J Urol 174: 984\u2013989","journal-title":"J Urol"},{"key":"1592_CR31","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1464-410X.2005.05725.x","volume":"96","author":"Rajkumar","year":"2005","unstructured":"Rajkumar GN, Small DR, Mustafa AW, Conn G (2005) A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity. BJU Int 96: 848\u2013852","journal-title":"BJU Int"},{"key":"1592_CR32","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.urology.2004.01.041","volume":"63","author":"Rapp","year":"2004","unstructured":"Rapp DE, Lucioni A, Katz EE et al. (2004) Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience. Urology 63: 1071\u20131075","journal-title":"Urology"},{"key":"1592_CR33","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0022-5347(01)69309-1","volume":"171","author":"Reitz","year":"2004","unstructured":"Reitz A, Schurch B (2004) Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity. J Urol 171: 805","journal-title":"J Urol"},{"key":"1592_CR34","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","volume":"45","author":"Reitz","year":"2004","unstructured":"Reitz A, Stohrer M, Kramer G et al. (2004) European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 45: 510\u2013515","journal-title":"Eur Urol"},{"key":"1592_CR35","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.ju.0000108892.35041.2d","volume":"171","author":"Riccabona","year":"2004","unstructured":"Riccabona M, Koen M, Schindler M et al. (2004) Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J Urol 171: 845\u2013848","journal-title":"J Urol"},{"key":"1592_CR36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-2002-23188","volume":"33","author":"Richter","year":"2002","unstructured":"Richter R, Schaaf V (2002) Botulinum-A-toxin for therapy of detrusor hyperreflexia in neurogenic bladders. Akt Urol 33: 141\u2013142","journal-title":"Akt Urol"},{"key":"1592_CR37","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1569-9056(06)60387-4","volume":"5","author":"Sahai","year":"2006","unstructured":"Sahai A, Khan S, Dasgupta P (2006) Botulinum toxin A is safe and effective in the treatment of patients with overactive bladder and idiopathic detrusor overactivity: results from a randomised, double-blind, placebo-controlled trial. Eur Urol 5: 118","journal-title":"Eur Urol"},{"key":"1592_CR38","doi-asserted-by":"crossref","unstructured":"Schmid D, John H, Hauri D, Schurch B (2006) Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics J Urol 176: 177\u2013185","DOI":"10.1016\/S0022-5347(06)00590-8"},{"key":"1592_CR39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0302-2838(03)00136-2","volume":"44","author":"Schulte-Baukloh","year":"2003","unstructured":"Schulte-Baukloh H, Michael T, Sturzebecher B, Knispel HH (2003) Botulinum-A toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder. Eur Urol 44: 139\u2013143","journal-title":"Eur Urol"},{"key":"1592_CR40","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.urology.2005.01.036","volume":"66","author":"Schulte-Baukloh","year":"2005","unstructured":"Schulte-Baukloh H, Weiss C, Stolze T et al. (2005) Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction. Urology 66: 82\u201387","journal-title":"Urology"},{"key":"1592_CR41","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.eururo.2005.06.021","volume":"48","author":"Schulte-Baukloh","year":"2005","unstructured":"Schulte-Baukloh H, Weiss C, Stolze T et al. (2005) Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction. Eur Urol 48: 984\u2013990","journal-title":"Eur Urol"},{"key":"1592_CR42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/nau.20153","volume":"25","author":"Schulte-Baukloh","year":"2006","unstructured":"Schulte-Baukloh H, Schobert J, Stolze T et al. (2006) Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis. Neurourol Urodyn 25: 110\u2013115","journal-title":"Neurourol Urodyn"},{"key":"1592_CR43","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM200003023420918","volume":"342","author":"Schurch","year":"2000","unstructured":"Schurch B, Schmid DM, Stohrer M (2000) Treatment of neurogenic incontinence with botulinum toxin A. N Engl J Med 342: 665","journal-title":"N Engl J Med"},{"key":"1592_CR44","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","volume":"164","author":"Schurch","year":"2000","unstructured":"Schurch B, Stohrer M, Kramer G et al. (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164: 692\u2013697","journal-title":"J Urol"},{"key":"1592_CR45","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","volume":"174","author":"Schurch","year":"2005","unstructured":"Schurch B, Seze M de, Denys P et al. (2005) Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 174: 196\u2013200","journal-title":"J Urol"},{"key":"1592_CR46","unstructured":"Staehler M, Sauter T, Miller K (2003) Botulinum toxin A injection in the M. detrusor vesicae replaces surgery in children with myelomeningocele. 33rd Annual Meeting of the International Continence Society, Florence, Italy: ICS; 2003"},{"key":"1592_CR47","unstructured":"St\u00f6hrer M, Schurch B, Kramer G et al. (1999) Botulinum A-Toxin in the treatment of detrusor hyperreflexia in spinal cord injured patients: a new alternative to medical and surgical procedures? 29th Annual Meeting of the International Continence Society, Denver"},{"key":"1592_CR48","unstructured":"Toh K, Tow A, Consigliere D (2005) Botulinum toxin type A for refractory detrusor overactivity in patients with spinal cord injuries in Asia: preliminary results. 35th Annual Meeting of the International Continence Society, Montreal, Quebec, Canada"},{"key":"1592_CR49","first-page":"69","volume":"93","author":"Verleyen","year":"2004","unstructured":"Verleyen P, Hoebeke P, Raes A et al. (2004) The use of botulinum toxin A in children with a non-neurogenic overactive bladder: A pilot study. BJU Int 93: 69","journal-title":"BJU Int"},{"key":"1592_CR50","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.ajog.2004.11.052","volume":"192","author":"Werner","year":"2005","unstructured":"Werner M, Schmid DM, Schussler B (2005) Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study. Am J Obstet Gynecol 192: 1735\u20131740","journal-title":"Am J Obstet Gynecol"},{"key":"1592_CR51","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.sc.3101318","volume":"40","author":"Wyndaele","year":"2002","unstructured":"Wyndaele JJ, Van Dromme SA (2002) Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity. Spinal Cord 40: 599\u2013600","journal-title":"Spinal Cord"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-007-1592-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-007-1592-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-007-1592-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T10:58:48Z","timestamp":1558609128000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-007-1592-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,24]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["1592"],"URL":"https:\/\/doi.org\/10.1007\/s00120-007-1592-2","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,24]]}}}